CTVA
Corteva, Inc.65.48
-0.40-0.61%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
44.47BP/E (TTM)
26.51Basic EPS (TTM)
2.47Dividend Yield
0.01%Recent Filings
8-K
8-K
Corteva plans tax-free split
Corteva announced plans to split into two public companies via a tax-free spin-off, with the Seed business as SpinCo and Crop Protection as New Corteva, set for completion in the second half of 2026. This move sharpens focus on divergent growth paths, unlocking tailored strategies for innovation and returns. New Corteva eyes biologicals amid competition; SpinCo leverages Pioneer genetics for yields. Yet risks loom if the split disrupts operations.
8-K
Corteva appoints new chief legal officer
Corteva announced Cornel Fuerer's retirement from his role as senior vice president and chief legal and public affairs officer, effective September 15, 2025, with Jennifer A. Johnson stepping in as the new chief legal officer on that date. Fuerer will retain public affairs oversight and corporate secretary duties until year-end 2025, then advise strategically through 2026. Johnson's agriculture tech expertise from DuPont and IFF promises smooth continuity. Leadership transitions like this keep operations steady.
10-Q
Q2 FY2025 results
Corteva's Q2 net sales climbed 6% year-over-year to $6,456M, fueled by 6% volume gains in Seed corn and Crop Protection fungicides, though a 1% currency hit tempered the rise; gross margins held steady at 55% amid raw material deflation and productivity wins, while operating income surged 35% to $1,804M on lower royalties and restructuring costs. Y/Y, diluted EPS from continuing operations rose 34% to $2.02, reconciling neatly with 683M shares, yet discontinued operations dragged net EPS to $1.92 after $66M PFAS charges. Cash dipped to $2.1B with $1.1B operating outflow from seasonal receivables buildup, offset by $5.5B credit availability and $3.6B debt at 4.5% average rate; free cash flow not disclosed in the 10-Q. The $875M NJ Statewide Settlement closed in August 2025 for cash over 25 years (NPV ~$500M per MOU shares), recognizing no new goodwill but flagging regulatory delays from EPA staffing cuts as a key risk.
8-K
Corteva boosts 2025 guidance
Corteva reported strong Q2 2025 results on August 6, with net sales up 6% to $6.46B and organic sales rising 7%, fueled by 6% volume growth across seed and crop protection segments. Operating EBITDA climbed 13% to $2.16B, margins expanded 215 basis points on cost discipline and North American market leadership, yet Latin American pricing pressured gains. It raised full-year guidance to $17.6B-$17.8B net sales and $3.00-$3.20 operating EPS. Strong cash flow enables $1B share repurchases.
IPO
Website
Employees
Sector
Industry
AVD
American Vanguard Corporation
4.02+0.00
BIOX
Bioceres Crop Solutions Corp.
1.51-0.04
CF
CF Industries Holdings, Inc.
77.55-1.20
FMC
FMC Corporation
13.16+0.04
GNVR
Genvor Incorporated
1.70+0.00
LVRO
Lavoro Limited
0.64-0.02
NTR
Nutrien Ltd.
61.85+0.00
SANW
S&W Seed Co.
0.06+0.00
SEED
Origin Agritech Limited
1.37+0.08
UAN
CVR Partners, LP
94.78-0.78